At the beginning of the three major indexes, the GEM index rose by 0.39%, and the concepts of quantum technology and chips led the gains.Facewall Intelligence has received a new round of financing of several hundred million yuan. Recently, Facewall Intelligence has completed a new round of financing of several hundred million yuan. This round of financing was jointly led by Loongson Venture Capital, Dinghui Baifu, Zhongguancun Science City Fund and Safran Investment Fund, and Beijing Artificial Intelligence Industry Investment Fund and Zero2IPO followed suit.Shangtang Technology completed the placement of a number of international funds, long-term funds and existing shareholders of about HK$ 2.8 billion. For the news that Shang Tang announced today that it plans to place 1.865 billion shares and raise HK$ 2.787 billion, the reporter learned that a number of internationally renowned funds, long-term funds and existing shareholders will participate, and the funds raised will be used to support the company's core business development, including building an industry AI cloud, upgrading the scale of Shang Tang's large-scale devices, supporting generative artificial intelligence, including large-scale model research and product development, and (science and technology innovation board Daily)
The opening rate of Maotai in 1935 increased, and today's wholesale reference price rose slightly. The latest wholesale reference price disclosed by today's wine price shows that on December 11th, Maotai reported 690 yuan/bottle in 1935, and Han sauce (Pu) reported 295 yuan/bottle, which were higher than the previous day by 5 yuan; In 24 years, the original box and bulk bottle of Feitian Maotai were reported at 2270 yuan/bottle and 2215 yuan/bottle respectively, which was the same as the previous day.Most gold stocks in Hong Kong stocks strengthened, and Zhaojin Mining rose by over 5%. As of press time, Zhaojin Mining (01818.HK) rose by 5.47%, Lingbao Gold (03330.HK) rose by 5.09% and Shandong Gold (01787.HK) rose by 2.26%.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.
Shanghai's state-owned assets reform concept stocks rose to the daily limit, and Shanghai Material Trade, First Medicine, Shibei High-tech, Kaikai Industry and Shanghai 900 set an international daily limit.Low-priced stocks were active repeatedly, and Mei Yan walked out of four boards in five days. In addition, more than 20 constituent stocks such as Pingtan Development, Smart Agriculture, Jin Zhengda, Zhongnan, Xiamen Industrial Co., Ltd. and Yabo Co., Ltd. had daily limit.YTO Express invested 30 million yuan in Hengyang City to set up a new company. The enterprise search APP shows that recently, Hengyang YTO Express Co., Ltd. was established, with the legal representative of Sun Kai and the registered capital of 30 million yuan. Its business scope includes: general cargo warehousing services; Domestic freight forwarder; Storage equipment rental service. Enterprise equity penetration shows that the company is indirectly wholly-owned by YTO Express.
Strategy guide
12-14
Strategy guide
12-14